Advertisement
Screener

Organon & Co. (OGN) Auditor

Organon & Co. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-24: Fiscal year end 2025-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Florham Park, New Jersey.
  • 2025-11-10: Fiscal year end 2024-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Florham Park, New Jersey.
  • 2025-02-28: Fiscal year end 2024-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Florham Park, New Jersey.
  • 2024-02-26: Fiscal year end 2023-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Florham Park, New Jersey.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-242025-12-31PricewaterhouseCoopers LLP238Florham Park, New JerseyYes
2025-11-102024-12-31PricewaterhouseCoopers LLP238Florham Park, New JerseyYes
2025-02-282024-12-31PricewaterhouseCoopers LLP238Florham Park, New JerseyYes
2024-02-262023-12-31PricewaterhouseCoopers LLP238Florham Park, New JerseyYes
2023-02-272022-12-31PricewaterhouseCoopers LLP238Florham Park, New JerseyYes
2022-03-212021-12-31PricewaterhouseCoopers LLP238Florham Park, New JerseyNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
ACADIA PHARMACEUTICALS INC (ACAD)United States$3.823B11.45
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
AbCellera Biologics Inc. (ABCL)$3.879B-14.59
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Arcus Biosciences, Inc. (RCUS)United States$3.188B-8.52
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
Tango Therapeutics, Inc. (TNGX)United States$4.154B-42.53